首页 > 最新文献

New Microbiologica最新文献

英文 中文
Research on the Artemia nauplii microorganism compositions based on metagenomics next-generation sequencing. 基于元基因组学新一代测序技术的蒿鱼稚鱼微生物组成研究。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01
Yang Xu, Dayan Hu, Haihua Cheng, Fei Peng, Qiang Gao

Vibrio species represent the predominant and significant pathogen in global marine fish and shellfish aquaculture. Vibrio species are ubiquitously presented in Artemia cyst hatcheries, and their notable colonization in live prey, particularly Artemia nauplii, leads to the transmission of these pathogens into the digestive system of larval organisms, causing serious problems in Vibriosis in marine aquaculture. To eliminate the Vibriospecies in Artemia nauplii, trichloroisocyanuric acid (TCCA) was used for sterilization of the nauplii. In this study, 3 different concentrations, including 0.5 ppm (FA group), 1.0 ppm (FB group) and 1.5 ppm (FC group) of TCCA were used to treat nauplii for 25 min, and then genomic DNA of the different groups were extracted followed by metagenomic next-generation sequencing (NGS). Bioinformatics analysis was applied and the results indicated that Proteobacter constituted the predominant component within each group at the phylum level, albeit accounting for only 58.68% in the FB group, which was significantly lower than in other groups (>86%). The relative abundance of Vibrio species at genus level showed that when compared with the control group, the FB group (15.8%) was reduced by 25.5%. Beta diversity showed differences between the FB group and the other groups, suggesting that treatment with 1.0ppm TCCA for 25 min would obviously reduce the Vibrio in Artemia nauplii. In conclusion, the Vibrio species were significantly reduced after treatment with TCCA, indicating that TCCA might be an alternative to antibiotics used for live food sterilization in marine aquaculture.

弧菌是全球海洋鱼类和贝类水产养殖中最主要和最重要的病原体。弧菌普遍存在于Artemia囊胚孵化场,其在活体猎物(尤其是Artemia稚鱼)中的显著定植会导致这些病原体传播到幼鱼的消化系统中,给海水养殖带来严重的弧菌病问题。为了消除笛鲷稚鳃中的弧菌,使用了三氯异氰尿酸(TCCA)对稚鳃进行消毒。本研究使用 3 种不同浓度的 TCCA 对稚虫处理 25 分钟,包括 0.5 ppm(FA 组)、1.0 ppm(FB 组)和 1.5 ppm(FC 组),然后提取不同组的基因组 DNA,进行元基因组下一代测序(NGS)。生物信息学分析结果表明,在门级水平上,蛋白菌在各组中占主要成分,但在 FB 组中仅占 58.68%,明显低于其他组(>86%)。弧菌属物种的相对丰度显示,与对照组相比,FB 组(15.8%)减少了 25.5%。Beta 多样性显示 FB 组与其他组之间存在差异,这表明用 1.0ppm TCCA 处理 25 分钟会明显减少蒿甲虫稚鱼中的弧菌。总之,经 TCCA 处理后,弧菌种类明显减少,这表明 TCCA 可替代抗生素用于海水养殖中的活体食物杀菌。
{"title":"Research on the Artemia nauplii microorganism compositions based on metagenomics next-generation sequencing.","authors":"Yang Xu, Dayan Hu, Haihua Cheng, Fei Peng, Qiang Gao","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Vibrio species represent the predominant and significant pathogen in global marine fish and shellfish aquaculture. Vibrio species are ubiquitously presented in Artemia cyst hatcheries, and their notable colonization in live prey, particularly Artemia nauplii, leads to the transmission of these pathogens into the digestive system of larval organisms, causing serious problems in Vibriosis in marine aquaculture. To eliminate the Vibriospecies in Artemia nauplii, trichloroisocyanuric acid (TCCA) was used for sterilization of the nauplii. In this study, 3 different concentrations, including 0.5 ppm (FA group), 1.0 ppm (FB group) and 1.5 ppm (FC group) of TCCA were used to treat nauplii for 25 min, and then genomic DNA of the different groups were extracted followed by metagenomic next-generation sequencing (NGS). Bioinformatics analysis was applied and the results indicated that Proteobacter constituted the predominant component within each group at the phylum level, albeit accounting for only 58.68% in the FB group, which was significantly lower than in other groups (>86%). The relative abundance of Vibrio species at genus level showed that when compared with the control group, the FB group (15.8%) was reduced by 25.5%. Beta diversity showed differences between the FB group and the other groups, suggesting that treatment with 1.0ppm TCCA for 25 min would obviously reduce the Vibrio in Artemia nauplii. In conclusion, the Vibrio species were significantly reduced after treatment with TCCA, indicating that TCCA might be an alternative to antibiotics used for live food sterilization in marine aquaculture.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139514262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing the antiretroviral treatment focusing on long-term effectiveness and a person-centered approach. Consensus Guidance Using a Delphi Process. 优化抗逆转录病毒治疗,注重长期有效性和以人为本的方法。使用德尔菲程序达成共识指南。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01
Franco Maggiolo, Sergio Lo Caputo, Stefano Bonora, Marco Borderi, Antonella Cingolani, Gabriella D'Ettorre, Antonio Di Biagio, Simona Di Giambenedetto, Cristina Gervasoni, Giovanni Guaraldi, Paolo Maggi, Lucia Taramasso

Definitive data on the long-term success of the latest antiretroviral therapy (ART) strategies are still lacking. A panel of infectious diseases specialists was convened to develop a consensus on how to tailor and follow ART over time. Panelists used a Delphi technique to develop a list of statements describing preferred management approaches for ART and patient monitoring and quality of life evaluation. Ninety infectious diseases specialists from several Infectious Diseases Centers in Italy participated in the consensus process. A consensus was reached on virological and immunological parameters to use to monitor long-term efficacy of antiretroviral treatment, while there was no consensus on the use of specific inflammation and immune-activation markers in clinical routine. The panel agreed on the need for an antiretroviral treatment with the lowest impact on bone, kidney and cardiovascular toxicity and on the utility of quality-of-life monitoring during the standard follow up of people living with HIV. The consensus statements developed by a panel of infectious diseases specialists may provide guidance to practitioners for a person-centered approach aimed at obtaining long-term virological and clinical success for people living with HIV.

目前仍缺乏最新抗逆转录病毒疗法(ART)策略长期成功的确切数据。为了就如何调整和长期跟踪抗逆转录病毒疗法达成共识,我们召集了一个由传染病专家组成的小组。专家小组成员采用德尔菲(Delphi)技术制定了一份陈述清单,描述了首选的抗逆转录病毒疗法管理方法以及患者监测和生活质量评估。来自意大利多家传染病中心的 90 名传染病专家参与了共识进程。专家组就用于监测抗逆转录病毒疗法长期疗效的病毒学和免疫学参数达成了共识,但对于在临床常规治疗中使用特定的炎症和免疫激活标志物则未达成共识。专家组一致认为,抗逆转录病毒治疗对骨骼、肾脏和心血管毒性的影响最小,而且在对艾滋病毒感染者进行标准随访期间,生活质量监测也很有用。传染病专家小组制定的共识声明可为从业人员提供指导,帮助他们采取以人为本的方法,为艾滋病病毒感染者取得长期病毒学和临床治疗的成功。
{"title":"Optimizing the antiretroviral treatment focusing on long-term effectiveness and a person-centered approach. Consensus Guidance Using a Delphi Process.","authors":"Franco Maggiolo, Sergio Lo Caputo, Stefano Bonora, Marco Borderi, Antonella Cingolani, Gabriella D'Ettorre, Antonio Di Biagio, Simona Di Giambenedetto, Cristina Gervasoni, Giovanni Guaraldi, Paolo Maggi, Lucia Taramasso","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Definitive data on the long-term success of the latest antiretroviral therapy (ART) strategies are still lacking. A panel of infectious diseases specialists was convened to develop a consensus on how to tailor and follow ART over time. Panelists used a Delphi technique to develop a list of statements describing preferred management approaches for ART and patient monitoring and quality of life evaluation. Ninety infectious diseases specialists from several Infectious Diseases Centers in Italy participated in the consensus process. A consensus was reached on virological and immunological parameters to use to monitor long-term efficacy of antiretroviral treatment, while there was no consensus on the use of specific inflammation and immune-activation markers in clinical routine. The panel agreed on the need for an antiretroviral treatment with the lowest impact on bone, kidney and cardiovascular toxicity and on the utility of quality-of-life monitoring during the standard follow up of people living with HIV. The consensus statements developed by a panel of infectious diseases specialists may provide guidance to practitioners for a person-centered approach aimed at obtaining long-term virological and clinical success for people living with HIV.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139514259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination effects of baicalin with linezolid against Staphylococcus aureus biofilm-related infections: in vivo animal model. 黄芩苷和利奈唑胺对金黄色葡萄球菌生物膜相关感染的联合作用:体内动物模型。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-09-01
Zhongye Du, Jiahui Han, Jing Luo, Guan Bi, Tangjuan Liu, Jinliang Kong, Yiqiang Chen

Staphylococcus aureus is a gram-positive bacterium that can produce biofilm, and biofilm-associated infections are difficult to control. Biofilm prevents antibiotics from penetrating and killing the bacteria. Combined use of antimicrobials is a common strategy to treat S. aureus biofilm-related infections. In this in vivo study, the clinically isolated strain of S. aureus 17546 (t037) was selected to establish a biofilm-associated infection rat model, and baicalin and linezolid were used to treat the infection. CFU counting was used to determine the bacteria within the biofilm, the biofilm structure was viewed using scanning electron microscopy (SEM), histopathology was performed, and inflammatory factors were analyzed by ELISA. Baicalin was efficient in destroying the biofilm and exerted a synergistic bactericidal effect when combined with linezolid. Based on these findings, baicalin combined with linezolid may be efficacious in controlling S. aureus biofilm-related infections.

金黄色葡萄球菌是一种能产生生物膜的革兰氏阳性细菌,与生物膜相关的感染很难控制。生物膜阻止抗生素穿透并杀死细菌。联合使用抗菌药物是治疗金黄色葡萄球菌生物膜相关感染的常用策略。在这项体内研究中,选择临床分离的金黄色葡萄球菌17546(t037)菌株建立生物膜相关感染大鼠模型,并使用黄芩苷和利奈唑胺治疗感染。CFU计数用于确定生物膜内的细菌,扫描电子显微镜(SEM)观察生物膜结构,进行组织病理学检查,ELISA分析炎症因子。黄芩苷能有效地破坏生物膜,并与利奈唑胺联合发挥协同杀菌作用。基于这些发现,黄芩苷联合利奈唑胺可能对控制金黄色葡萄球菌生物膜相关感染有效。
{"title":"Combination effects of baicalin with linezolid against Staphylococcus aureus biofilm-related infections: in vivo animal model.","authors":"Zhongye Du,&nbsp;Jiahui Han,&nbsp;Jing Luo,&nbsp;Guan Bi,&nbsp;Tangjuan Liu,&nbsp;Jinliang Kong,&nbsp;Yiqiang Chen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Staphylococcus aureus is a gram-positive bacterium that can produce biofilm, and biofilm-associated infections are difficult to control. Biofilm prevents antibiotics from penetrating and killing the bacteria. Combined use of antimicrobials is a common strategy to treat S. aureus biofilm-related infections. In this in vivo study, the clinically isolated strain of S. aureus 17546 (t037) was selected to establish a biofilm-associated infection rat model, and baicalin and linezolid were used to treat the infection. CFU counting was used to determine the bacteria within the biofilm, the biofilm structure was viewed using scanning electron microscopy (SEM), histopathology was performed, and inflammatory factors were analyzed by ELISA. Baicalin was efficient in destroying the biofilm and exerted a synergistic bactericidal effect when combined with linezolid. Based on these findings, baicalin combined with linezolid may be efficacious in controlling S. aureus biofilm-related infections.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41165700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fosfomycin-meropenem synergistic combination against NDM carbapenemase-producing Klebsiella pneumoniae strains. 磷霉素-美罗培南协同组合对抗NDM碳青霉烯酶产生的肺炎克雷伯菌菌株。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-09-01
Maria Teresa Della Rocca, Giovanni Di Caprio, Francesca Colucci, Filomena Merola, Vittorio Panetta, Emanuele Cordua, Rita Greco

Carbapenemase-producing Enterobacteriaceae (CPE) are an increasing threat to global public health. Treatment of CPE isolates, like New Delhi metallo-β-lactamase (NDM), is limited and often necessitates combination therapies. The aim of this study was to evaluate the synergistic meropenem/fosfomycin combination against K.pneumoniae-producing NDM isolates. Fosfomycin/meropenem, fosfomycin/colistin and meropenem/colistin were tested alone and in combination, using e-test and time-kill assay against 20 clinical carbapenemase-producing K. pneumonia (CPKp NDM) isolates collected from September 2022 to December 2022. K. pneumoniae strains were resistant to meropenem, ceftazidime/avibactam and ceftolozano/tazobactam, 75% and 80% of isolates were susceptible for cefiderocol and for colistin respectively. Fosfomycin/meropenem combination was synergic in 95% (n=19) strains. Fosfomycin/colistin and colistin/meropenem combination showed only 10% synergistic combination strains. In 16 isolates (80%) indifference action for fosfomycin/colistin and colistin/meropenem was reported. For 0.8% of CpKP NDM isolates colistin/meropenem and fosfomycin/colistin combinations found to be antagonistic. In this study, time kill assay showed combination therapies action versus K.pneumoniae metallo-b-lactamase producing (NDM) strains and confirmed the synergistic action of fosfomycin/meropenem combination. In vitro synergy testing should be routinely performed in multidrug resistance infections and combo therapies can be used as a possible alternative in targeted patients with the goal of reducing overall antibiotic costs.

产碳青霉烯酶的肠杆菌科(CPE)对全球公众健康的威胁越来越大。CPE分离株的治疗,如新德里金属β-内酰胺酶(NDM),是有限的,通常需要联合治疗。本研究的目的是评估美罗培南/磷霉素联合用药对产肺炎克雷伯菌NDM分离株的协同作用。针对2022年9月至2022年12月收集的20个临床产碳青霉烯酶的肺炎克氏菌(CPKp-NDM)分离株,使用电子试验和时间杀伤试验,单独和联合检测磷霉素/美罗培南、磷霉素-粘菌素和美罗培南/粘菌素。肺炎克雷伯菌对美罗培南、头孢他啶/阿维巴坦和头孢托洛扎诺/他唑巴坦具有耐药性,分别有75%和80%的分离株对头孢iderocol和粘菌素敏感。磷霉素/美罗培南组合对95%(n=19)菌株具有协同作用。磷霉素/粘菌素和粘菌素/美罗培南组合菌株的增效率仅为10%。在16个分离株中(80%)报道了磷霉素/粘菌素和粘菌素/美罗培南的无差异作用。对于0.8%的CpKP NDM分离株,发现粘菌素/美罗培南和磷霉素/粘菌素组合具有拮抗作用。在本研究中,时间杀伤试验显示了联合治疗对肺炎克雷伯菌产生金属-β-乳糖酶(NDM)菌株的作用,并证实了磷霉素/美罗培南联合治疗的协同作用。体外协同作用测试应在多药耐药性感染中常规进行,联合疗法可作为靶向患者的可能替代方案,以降低总体抗生素成本。
{"title":"Fosfomycin-meropenem synergistic combination against NDM carbapenemase-producing Klebsiella pneumoniae strains.","authors":"Maria Teresa Della Rocca,&nbsp;Giovanni Di Caprio,&nbsp;Francesca Colucci,&nbsp;Filomena Merola,&nbsp;Vittorio Panetta,&nbsp;Emanuele Cordua,&nbsp;Rita Greco","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Carbapenemase-producing Enterobacteriaceae (CPE) are an increasing threat to global public health. Treatment of CPE isolates, like New Delhi metallo-β-lactamase (NDM), is limited and often necessitates combination therapies. The aim of this study was to evaluate the synergistic meropenem/fosfomycin combination against K.pneumoniae-producing NDM isolates. Fosfomycin/meropenem, fosfomycin/colistin and meropenem/colistin were tested alone and in combination, using e-test and time-kill assay against 20 clinical carbapenemase-producing K. pneumonia (CPKp NDM) isolates collected from September 2022 to December 2022. K. pneumoniae strains were resistant to meropenem, ceftazidime/avibactam and ceftolozano/tazobactam, 75% and 80% of isolates were susceptible for cefiderocol and for colistin respectively. Fosfomycin/meropenem combination was synergic in 95% (n=19) strains. Fosfomycin/colistin and colistin/meropenem combination showed only 10% synergistic combination strains. In 16 isolates (80%) indifference action for fosfomycin/colistin and colistin/meropenem was reported. For 0.8% of CpKP NDM isolates colistin/meropenem and fosfomycin/colistin combinations found to be antagonistic. In this study, time kill assay showed combination therapies action versus K.pneumoniae metallo-b-lactamase producing (NDM) strains and confirmed the synergistic action of fosfomycin/meropenem combination. In vitro synergy testing should be routinely performed in multidrug resistance infections and combo therapies can be used as a possible alternative in targeted patients with the goal of reducing overall antibiotic costs.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41174922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Talaromyces marneffei infection in an HIV infected patient with hematological malignancy - first report from Turkey. 一名血液系统恶性肿瘤的HIV感染患者中的Talaromyces marneffei感染——土耳其首次报告。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-09-01
Ahmet Furkan Kurt, Ebru Cicek, Tamer A M Alhelou, Bilgul Mete, Ridvan Karaali, Mert Ahmet Kuskucu, Zeynep Yazgan, Hatice Yasar Arsu, Sibel Yıldız Kaya, Gokhan Aygun, Fehmi Tabak

T.marneffei, encountered mostly in Southeast Asia, leads to a systemic infection, especially in immunocompromised individuals such as HIV-infected patients with low CD4 level. A 32-year-old male patient, residing in Hong Kong for the last two years, admitted with fever, cough, weakness, and weight loss. Physical examination revealed bilateral cervical and axillary multiple lymph nodes and hepatosplenomegaly. Screening of the pancytopenic patient revealed HIV infection. Histopathological examination of the cervical lymph node revealed plasmoblastic lymphoma. Blood and urine cultures remained sterile. Antiretroviral therapy was started. Fungal hyphae were detected in Gram staining of hemocultures taken in the third week due to ongoing fever, and antifungal therapy was started empirically. Red pigment around colonies on Sabouraud dextrose agar and microscopic appearance arose suspicion of Talaromyces spp. T.marneffei was identified by ITS 1-4 sequence analysis. Chemotherapy was started when fungemia was controlled. On the fifth day of chemotherapy, the patient's general condition deteriorated, broad-spectrum antibiotics were started and the patient was transferred to ICU. The cultures remained sterile and he expired five days later. In conclusion, although talaromycosis is not endemic in Turkey, it should be considered in patients with travel history to endemic regions and/or an underlying immunosuppressive disease such as HIV infection.

T.marneffei主要发生在东南亚,会导致全身感染,尤其是在免疫功能低下的个体中,如CD4水平低的HIV感染患者。一名32岁男性患者,过去两年居住在香港,因发烧、咳嗽、虚弱和体重减轻入院。体格检查显示双侧颈腋窝多发淋巴结及肝脾肿大。对全血细胞减少症患者的筛查显示感染了艾滋病毒。颈部淋巴结的组织病理学检查显示为浆母细胞淋巴瘤。血液和尿液培养物保持无菌。开始了抗逆转录病毒治疗。由于持续发烧,在第三周进行的血液培养的革兰氏染色中检测到真菌菌丝,并根据经验开始抗真菌治疗。Sabouraud葡萄糖琼脂菌落周围的红色色素和显微镜外观引起了对Talaromyces spp.T.marneffei的怀疑。通过ITS 1-4序列分析鉴定了T.marneffi。真菌血症得到控制后开始化疗。在化疗的第五天,患者的总体情况恶化,开始使用广谱抗生素,并将患者转移到ICU。培养物仍然是无菌的,五天后他就死了。总之,尽管距骨霉菌病在土耳其不是地方病,但有前往地方病流行地区旅行史和/或潜在的免疫抑制疾病(如HIV感染)的患者应考虑使用该病。
{"title":"Talaromyces marneffei infection in an HIV infected patient with hematological malignancy - first report from Turkey.","authors":"Ahmet Furkan Kurt,&nbsp;Ebru Cicek,&nbsp;Tamer A M Alhelou,&nbsp;Bilgul Mete,&nbsp;Ridvan Karaali,&nbsp;Mert Ahmet Kuskucu,&nbsp;Zeynep Yazgan,&nbsp;Hatice Yasar Arsu,&nbsp;Sibel Yıldız Kaya,&nbsp;Gokhan Aygun,&nbsp;Fehmi Tabak","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>T.marneffei, encountered mostly in Southeast Asia, leads to a systemic infection, especially in immunocompromised individuals such as HIV-infected patients with low CD4 level. A 32-year-old male patient, residing in Hong Kong for the last two years, admitted with fever, cough, weakness, and weight loss. Physical examination revealed bilateral cervical and axillary multiple lymph nodes and hepatosplenomegaly. Screening of the pancytopenic patient revealed HIV infection. Histopathological examination of the cervical lymph node revealed plasmoblastic lymphoma. Blood and urine cultures remained sterile. Antiretroviral therapy was started. Fungal hyphae were detected in Gram staining of hemocultures taken in the third week due to ongoing fever, and antifungal therapy was started empirically. Red pigment around colonies on Sabouraud dextrose agar and microscopic appearance arose suspicion of Talaromyces spp. T.marneffei was identified by ITS 1-4 sequence analysis. Chemotherapy was started when fungemia was controlled. On the fifth day of chemotherapy, the patient's general condition deteriorated, broad-spectrum antibiotics were started and the patient was transferred to ICU. The cultures remained sterile and he expired five days later. In conclusion, although talaromycosis is not endemic in Turkey, it should be considered in patients with travel history to endemic regions and/or an underlying immunosuppressive disease such as HIV infection.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41156629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidrug resistance and high genotypic diversity in Campylobacter upsaliensis from household dogs in Metro Manila, Philippines. 菲律宾马尼拉大都会家犬上沙弯曲杆菌的多药耐药性和高基因型多样性。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-09-01
Ma Socorro Edden Palacio Subejano, Gil Mallari Penuliar

Campylobacter upsaliensis is an emerging pathogen implicated in human gastroenteritis. Contact with pets, especially dogs, has been identified as a risk factor. Fourteen (14) C. upsaliensis isolates were obtained from household dogs in Metro Manila, Philippines. Antimicrobial susceptibility testing (AST) determined high resistance to ciprofloxacin (92.86%), erythromycin (100%), and tetracycline (100%). Multilocus sequence typing (MLST) identified 14 novel sequence types and 1 novel clonal complex, which is suggestive of a high genotypic diversity within C. upsaliensis. AST results indicate that antimicrobial stewardship and education of pet owners should be emphasised in veterinary practice.

upsaliensis弯曲杆菌是一种新出现的与人类胃肠炎有关的病原体。接触宠物,尤其是狗,已被确定为一个风险因素。从菲律宾马尼拉大都会的家犬身上获得了十四(14)个升麻C.upsaliensis分离株。抗菌药敏试验(AST)确定对环丙沙星(92.86%)、红霉素(100%)和四环素(100%)具有高耐药性。多基因座序列分型(MLST)鉴定了14种新的序列类型和1种新的克隆复合体,这表明升麻中具有较高的基因型多样性。AST结果表明,在兽医实践中应重视宠物主人的抗菌管理和教育。
{"title":"Multidrug resistance and high genotypic diversity in Campylobacter upsaliensis from household dogs in Metro Manila, Philippines.","authors":"Ma Socorro Edden Palacio Subejano,&nbsp;Gil Mallari Penuliar","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Campylobacter upsaliensis is an emerging pathogen implicated in human gastroenteritis. Contact with pets, especially dogs, has been identified as a risk factor. Fourteen (14) C. upsaliensis isolates were obtained from household dogs in Metro Manila, Philippines. Antimicrobial susceptibility testing (AST) determined high resistance to ciprofloxacin (92.86%), erythromycin (100%), and tetracycline (100%). Multilocus sequence typing (MLST) identified 14 novel sequence types and 1 novel clonal complex, which is suggestive of a high genotypic diversity within C. upsaliensis. AST results indicate that antimicrobial stewardship and education of pet owners should be emphasised in veterinary practice.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41161088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thanatomicrobiome in forensic medicine. 法医学中的Thanatomicrobiome。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-09-01
Ahlam Abdoun, Nadir Amir, Mokrane Fatima

The circumstances of death and the estimation of the post-mortem interval (PMI) are often a great challenge for scientific and judicial investigators, especially when some time has elapsed since death. Several techniques are used; nevertheless, each presents its own limitations. In the quest for new techniques that are more reliable or at least complementary to those existing and sometimes less expensive, researchers have in recent years turned toward exploring the dynamics of the different microbial communities of a corpse according to their different stages of decomposition. This article summarizes the various works done in the field and shows the different sources of microorganisms in the different parts of the human corpse and their potential interest in the field of forensic medicine.

死亡情况和验尸间隔的估计对科学和司法调查人员来说往往是一个巨大的挑战,尤其是在死亡后一段时间后。使用了几种技术;然而,每一个都有其自身的局限性。为了寻找更可靠或至少与现有技术互补、有时成本更低的新技术,研究人员近年来转向根据尸体不同分解阶段探索尸体不同微生物群落的动力学。本文总结了该领域的各种工作,并展示了人体不同部位微生物的不同来源及其在法医学领域的潜在兴趣。
{"title":"Thanatomicrobiome in forensic medicine.","authors":"Ahlam Abdoun,&nbsp;Nadir Amir,&nbsp;Mokrane Fatima","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The circumstances of death and the estimation of the post-mortem interval (PMI) are often a great challenge for scientific and judicial investigators, especially when some time has elapsed since death. Several techniques are used; nevertheless, each presents its own limitations. In the quest for new techniques that are more reliable or at least complementary to those existing and sometimes less expensive, researchers have in recent years turned toward exploring the dynamics of the different microbial communities of a corpse according to their different stages of decomposition. This article summarizes the various works done in the field and shows the different sources of microorganisms in the different parts of the human corpse and their potential interest in the field of forensic medicine.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41163824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The investigation of community-acquired and nosocomial respiratory syncytial virus and other viral respiratory tract infections in children. 儿童社区获得性和医院感染呼吸道合胞病毒及其他病毒性呼吸道感染的调查。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-09-01
Serap Özen, Özden Özgür Horoz, Gökhan Öztürk, Huri Sökmen, Tülay Kandemir, Fügen Yarkin

Although respiratory viruses are known as the major causes of community-acquired respiratory tract infections all over the world, they can also cause serious nosocomial respiratory infections and hospital outbreaks. The aim of this study is to investigate the incidence of community-acquired and nosocomial RSV and other viral respiratory tract infections in children hospitalized at the Pediatric Intensive Care Unit of Cukurova University Faculty of Medicine. Nasopharyngeal swab samples were taken from 100 children aged 0-16 years with suspected community-acquired (60) and nosocomial (40) respiratory tract infections from September 2018 to June 2021. The Multiplex real-time PCR test was used for the diagnosis of respiratory viruses. Of children with community-acquired respiratory tract infections, 65% (39/60) were positive for at least one virus and the rate of coinfection in this group was 35.9% (14/39). In children with nosocomial respiratory tract infection, positivity was detected to be 62.5% (25/40) and the coinfection rate was 40% (10/25). The most predominant virus in community-acquired respiratory tract infections was influenza A virus (25%), followed by ADV (18.3%), hBoV (15%), RSV (11.7%), and RhV (10%). In nosocomial viral respiratory tract infections, the most common virus was RSV (20%), followed by influenza A virus (12.5%), RhV (12.5%), ADV (12.5%), hMpV (10%), and hBoV (10%). Early diagnosis of respiratory viral infections with real-time PCR test is important in terms of reducing morbidity and mortality, applying control methods to prevent the spread of nosocomial viruses, shortening the hospitalization period, preventing the use of unnecessary antibiotics, and giving appropriate antiviral treatment.

尽管呼吸道病毒是世界各地社区获得性呼吸道感染的主要原因,但它们也会导致严重的医院呼吸道感染和医院爆发。本研究的目的是调查在库库洛娃大学医学院儿科重症监护室住院的儿童中社区获得性和医院获得性呼吸道合胞病毒和其他病毒性呼吸道感染的发生率。从2018年9月至2021年6月,从100名0-16岁疑似社区获得性(60)和医院获得性(40)呼吸道感染的儿童身上采集鼻咽拭子样本。多重实时PCR检测用于呼吸道病毒的诊断。在社区获得性呼吸道感染的儿童中,65%(39/60)的儿童至少有一种病毒呈阳性,该组的合并感染率为35.9%(14/39)。在医院感染的儿童中,阳性率为62.5%(25/40),合并感染率为40%(10/25)。社区获得性呼吸道感染中最主要的病毒是甲型流感病毒(25%),其次是ADV(18.3%)、hBoV(15%)、RSV(11.7%)和RhV(10%)。在医院感染的病毒性呼吸道感染中,最常见的病毒是呼吸道合胞病毒(20%),其次是甲型流感病毒(12.5%)、RhV(12.5%),ADV(12.5%)、hMpV(10%)和hBoV(10%)。实时PCR检测对呼吸道病毒感染的早期诊断在降低发病率和死亡率、应用控制方法防止医院病毒传播、缩短住院时间、防止使用不必要的抗生素以及给予适当的抗病毒治疗方面很重要。
{"title":"The investigation of community-acquired and nosocomial respiratory syncytial virus and other viral respiratory tract infections in children.","authors":"Serap Özen,&nbsp;Özden Özgür Horoz,&nbsp;Gökhan Öztürk,&nbsp;Huri Sökmen,&nbsp;Tülay Kandemir,&nbsp;Fügen Yarkin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Although respiratory viruses are known as the major causes of community-acquired respiratory tract infections all over the world, they can also cause serious nosocomial respiratory infections and hospital outbreaks. The aim of this study is to investigate the incidence of community-acquired and nosocomial RSV and other viral respiratory tract infections in children hospitalized at the Pediatric Intensive Care Unit of Cukurova University Faculty of Medicine. Nasopharyngeal swab samples were taken from 100 children aged 0-16 years with suspected community-acquired (60) and nosocomial (40) respiratory tract infections from September 2018 to June 2021. The Multiplex real-time PCR test was used for the diagnosis of respiratory viruses. Of children with community-acquired respiratory tract infections, 65% (39/60) were positive for at least one virus and the rate of coinfection in this group was 35.9% (14/39). In children with nosocomial respiratory tract infection, positivity was detected to be 62.5% (25/40) and the coinfection rate was 40% (10/25). The most predominant virus in community-acquired respiratory tract infections was influenza A virus (25%), followed by ADV (18.3%), hBoV (15%), RSV (11.7%), and RhV (10%). In nosocomial viral respiratory tract infections, the most common virus was RSV (20%), followed by influenza A virus (12.5%), RhV (12.5%), ADV (12.5%), hMpV (10%), and hBoV (10%). Early diagnosis of respiratory viral infections with real-time PCR test is important in terms of reducing morbidity and mortality, applying control methods to prevent the spread of nosocomial viruses, shortening the hospitalization period, preventing the use of unnecessary antibiotics, and giving appropriate antiviral treatment.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41179307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy. 意大利伦巴第一家三级医院因2019年冠状病毒病(新冠肺炎)住院的慢性肝病患者的死亡风险。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-09-01
Martina Ranzenigo, Daniele Ceccarelli, Laura Galli, Costanza Bertoni, Alessia Siribelli, Emanuela Messina, Hamid Hasson, Riccardo Lolatto, Antonella Castagna, Caterina Uberti-Foppa, Giulia Morsica

The impact of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection on patients with pre-existing chronic liver diseases (CLD) remains elusive. The aim of this study was to investigate the in-hospital mortality in patients hospitalized for Coronavirus disease of 2019 (COVID-19) with CLD (CLD group) compared to those without CLD (non-CLD group). We performed a retrospective cohort study including patients with confirmed SARS-CoV-2 infection, hospitalized at San Raffaele Hospital (Milan), stratified according to the presence or absence of CLD. A propensity score was estimated and used to match the two groups by age, gender, body mass index, type 2 diabetes mellitus, and hypertension. Predictors of mortality were assessed using univariate and multivariate logistic regression model. Among 1210 patients with COVID-19, 41 (3.4%) were included in the CLD group and 1169 (96.6%) in the non-CLD group. Using a propensity score, we matched 41 patients in the CLD group with 123 in the non-CLD group. At admission, patients in the CLD group had worse liver function, lower platelets count, and lower c-reactive protein levels. By multivariate analysis, the CLD group showed a higher risk of death: OR 4.04 (95% CI 1.29-12.70; p= 0.017). Our study showed that COVID-19 with chronic liver diseases has a higher risk of mortality during hospitalization.

严重急性呼吸系统综合征冠状病毒2型(SARS-CoV-2)感染对已有慢性肝病(CLD)患者的影响仍然难以捉摸。本研究的目的是调查2019年因患有CLD(CLD组)的冠状病毒病(新冠肺炎)住院患者与未患有CLD的患者(非CLD组的患者)的住院死亡率。我们进行了一项回顾性队列研究,包括在米兰圣拉斐尔医院住院的确诊严重急性呼吸系统综合征冠状病毒2型感染患者,根据CLD的存在与否进行分层。评估倾向评分,并根据年龄、性别、体重指数、2型糖尿病和高血压对两组进行匹配。使用单变量和多变量逻辑回归模型评估死亡率的预测因素。在1210名新冠肺炎患者中,CLD组有41人(3.4%),非CLD组1169人(96.6%)。使用倾向评分,我们将CLD组的41名患者与非CLD组中的123名患者进行了匹配。入院时,CLD组患者的肝功能较差,血小板计数较低,c反应蛋白水平较低。通过多变量分析,CLD组的死亡风险较高:OR 4.04(95%CI 1.29-12.70;p=0.017)。我们的研究表明,患有慢性肝病的新冠肺炎在住院期间死亡风险较高。
{"title":"Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy.","authors":"Martina Ranzenigo,&nbsp;Daniele Ceccarelli,&nbsp;Laura Galli,&nbsp;Costanza Bertoni,&nbsp;Alessia Siribelli,&nbsp;Emanuela Messina,&nbsp;Hamid Hasson,&nbsp;Riccardo Lolatto,&nbsp;Antonella Castagna,&nbsp;Caterina Uberti-Foppa,&nbsp;Giulia Morsica","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The impact of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection on patients with pre-existing chronic liver diseases (CLD) remains elusive. The aim of this study was to investigate the in-hospital mortality in patients hospitalized for Coronavirus disease of 2019 (COVID-19) with CLD (CLD group) compared to those without CLD (non-CLD group). We performed a retrospective cohort study including patients with confirmed SARS-CoV-2 infection, hospitalized at San Raffaele Hospital (Milan), stratified according to the presence or absence of CLD. A propensity score was estimated and used to match the two groups by age, gender, body mass index, type 2 diabetes mellitus, and hypertension. Predictors of mortality were assessed using univariate and multivariate logistic regression model. Among 1210 patients with COVID-19, 41 (3.4%) were included in the CLD group and 1169 (96.6%) in the non-CLD group. Using a propensity score, we matched 41 patients in the CLD group with 123 in the non-CLD group. At admission, patients in the CLD group had worse liver function, lower platelets count, and lower c-reactive protein levels. By multivariate analysis, the CLD group showed a higher risk of death: OR 4.04 (95% CI 1.29-12.70; p= 0.017). Our study showed that COVID-19 with chronic liver diseases has a higher risk of mortality during hospitalization.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41152476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monkeypox virus transmission in tattoo parlor. 猴痘病毒在纹身店传播。
IF 1.8 4区 医学 Q2 Medicine Pub Date : 2023-09-01
Carlo Tascini, Francesco Sbrana, Simone Giuliano, Monica Geminiani, Alberto Pagotto

In monkeypox virus (MPXV) transmission caused by contaminated material, we have to consider that recently the outbreak of several MPXV cases was linked to tattoo parlors in Cadiz, Spain. These tattoo parlors did not cause a single outbreak, but instead are an established transmission route for MPXV, underscoring the need for increased awareness. We recommend increasing awareness among tattooists and piercers not only to protect their own safety and health, but also to prevent spreading the virus to their customers. Personal protective equipment such as gloves should be utilized and vaccination can be considered for those at risk of occupational exposure.

在猴痘病毒(MPXV)由受污染材料引起的传播中,我们必须考虑到最近爆发的几例MPXV病例与西班牙加的斯的纹身店有关。这些纹身店并没有导致一次疫情爆发,而是MPXV的既定传播途径,强调了提高认识的必要性。我们建议纹身师和穿孔者提高意识,不仅要保护自己的安全和健康,还要防止病毒传播给顾客。应使用手套等个人防护设备,并可考虑为有职业暴露风险的人接种疫苗。
{"title":"Monkeypox virus transmission in tattoo parlor.","authors":"Carlo Tascini,&nbsp;Francesco Sbrana,&nbsp;Simone Giuliano,&nbsp;Monica Geminiani,&nbsp;Alberto Pagotto","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In monkeypox virus (MPXV) transmission caused by contaminated material, we have to consider that recently the outbreak of several MPXV cases was linked to tattoo parlors in Cadiz, Spain. These tattoo parlors did not cause a single outbreak, but instead are an established transmission route for MPXV, underscoring the need for increased awareness. We recommend increasing awareness among tattooists and piercers not only to protect their own safety and health, but also to prevent spreading the virus to their customers. Personal protective equipment such as gloves should be utilized and vaccination can be considered for those at risk of occupational exposure.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41159727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
New Microbiologica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1